Last news
CNOOC Limited Announces A Hundred-Million-Ton Oilfield Discovery of Huizhou 19-6

CNOOC Limited Announces A Hundred-Million-Ton Oilfield Discovery of Huizhou 19-6

HONG KONG, March 31, 2025 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) announces today that the Company has made a major oilfield discovery of Huizhou 19-6 in the deep and ultra-deep...

Patent Index 2024: Japan ranks 3rd in European patent applications

Patent Index 2024: Japan ranks 3rd in European patent applications

European Patent Office received nearly 200 000 patent applications last year, with Japanese companies and inventors filing 10.6% of the total Electrical machinery/energy, transport and computers are leading technology fields for Japanese inventions...

Roborock Unveils Groundbreaking Saros Series in Australia

Roborock Unveils Groundbreaking Saros Series in Australia

Featuring World-First Robotic Arm Technology and Smarter, Slimmer Cleaning for Aussie Homes SYDNEY, March 31, 2025 /PRNewswire/ -- Roborock, a global leader in ultra-intelligent home robotics, today announced the arrival of its revolutionary Saros...

AWP Services New Zealand Limited t/a Allianz Partners forges a strategic partnership with Mitsui Sumitomo Insurance Company, Limited

AWP Services New Zealand Limited t/a Allianz Partners forges a strategic partnership with Mitsui Sumitomo Insurance Company, Limited

AUCKLAND, New Zealand, March 31, 2025 /PRNewswire/ -- Allianz Partners New Zealand and Mitsui Sumitomo Insurance Company Limited New Zealand Branch ("MSI NZ"), a member of MS&AD Insurance Group, are excited to announce a multi-year agreement,...

Akeso's 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies

Akeso's 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies

Key Highlights: Global first "immuno + anti-vascular" bispecific antibody approved: ivonescimab for EGFR-TKI resistant nsq-NSCLC. Phase III HARMONi study topline data expected mid-2025 (FDA FTD). ivonescimab outperforms pembrolizumab in Phase III...

Global Times: Practitioners' Insights: Practice of 'feedback window for unfinished work' in Anji showcases CPC's people-centric approach

Global Times: Practitioners' Insights: Practice of 'feedback window for unfinished work' in Anji showcases CPC's people-centric approach

BEIJING, March 31, 2025 /PRNewswire/ -- Government service halls across many regions in China have established dedicated feedback windows for handling unfinished work. What is such window? Out of the curiosity, the Global Times recently visited the...

BFA's 10th Religious Sub-forum Highlights Global Digitization Project of Buddhist Scriptures

BFA's 10th Religious Sub-forum Highlights Global Digitization Project of Buddhist Scriptures

QIONGHAI, China, March 30, 2025 /PRNewswire/ -- The Sub-forum on Religious Harmony and Mutual Learning Among Civilizations took place at the BFA (BFA) Annual Conference 2025 on March 28. The sub-forum focused on the theme "Countless Dharma Doors...

Fosun International Announces 2024 Annual Results: Total Revenue Reaches RMB192.14 Billion, Industrial Operation Profit Amounts to RMB4.9 Billion, Overall Operational Fundamentals Remain Stable

Fosun International Announces 2024 Annual Results: Total Revenue Reaches RMB192.14 Billion, Industrial Operation Profit Amounts to RMB4.9 Billion, Overall Operational Fundamentals Remain Stable

2024 Annual Results Highlights: Total revenue reached RMB192.14 billion; Industrial operation profit amounted to RMB4.9 billion; Total revenue generated by the four core subsidiaries amounted to RMB134.65 billion, accounting for 70.1% of the Group's...

menu
menu